HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma.

Abstract
Multiple myeloma (MM) is the second most common hematological malignancy, arising from terminally differentiated B cells, namely plasma cells. miRNAs are small non-coding RNAs that participate in the post-transcriptional regulation of gene expression. In this study, we investigated the role of nine miRNAs in MM. CD138+ plasma cells were selected from bone marrow aspirates from MM and smoldering MM (sMM) patients. Total RNA was extracted and in vitro polyadenylated. Next, first-strand cDNA synthesis was performed using an oligo-dT-adapter primer. For the relative quantification of the investigated miRNAs, an in-house real-time quantitative PCR (qPCR) assay was developed. A functional in silico analysis of the miRNAs was also performed. miR-16-5p and miR-155-5p expression was significantly lower in the CD138+ plasma cells of MM patients than in those of sMM patients. Furthermore, lower levels of miR-15a-5p, miR-16-5p, and miR-222-3p were observed in the CD138+ plasma cells of MM patients with osteolytic bone lesions, compared to those without. miR-125b-5p was also overexpressed in the CD138+ plasma cells of MM patients with bone disease that presented with skeletal-related events (SREs). Furthermore, lower levels of miR-223-3p were associated with significantly worse overall survival in MM patients. In conclusion, we propose a miRNA signature with putative clinical utility in MM.
AuthorsAristea-Maria Papanota, Paraskevi Karousi, Christos K Kontos, Pinelopi I Artemaki, Christine-Ivy Liacos, Maria-Alexandra Papadimitriou, Tina Bagratuni, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Efstathios Kastritis, Margaritis Avgeris, Meletios-Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 22 Issue 23 (Dec 05 2021) ISSN: 1422-0067 [Electronic] Switzerland
PMID34884950 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • MIRN125 microRNA, human
  • MIRN15 microRNA, human
  • MIRN16 microRNA, human
  • MIRN222 microRNA, human
  • MIRN223 microRNA, human
  • MicroRNAs
  • SDC1 protein, human
  • Syndecan-1
Topics
  • Adult
  • Aged
  • Biomarkers, Tumor (genetics)
  • Female
  • Gene Expression Profiling (methods)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • MicroRNAs (genetics)
  • Middle Aged
  • Multiple Myeloma (genetics, immunology)
  • Survival Analysis
  • Syndecan-1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: